hubXchange’s Cell Therapy Manufacturing Xchange Boston 2024, brings together executives from pharma and biotech to address and find solutions to the key issues faced in cell therapy manufacturing.

Discussion topics will cover iPSCs Technology, Autologous, Allogeneic, Measuring Product Potency.

Seiga Ohmine, Ph.D. Global head of Technical Sales will be facilitating a round table discussion on “De-risking programs and improving timelines when transitioning from pre-clinical to first in-human and ultimately, commercial production”.

The team from WuXi Advanced Therapies will be in attendance and would be happy to schedule time to meet!